A detailed history of Centaurus Financial, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Centaurus Financial, Inc. holds 14,015 shares of TEVA stock, worth $239,796. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,015
Holding current value
$239,796
% of portfolio
0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 20, 2024

BUY
$12.78 - $17.4 $179,111 - $243,860
14,015 New
14,015 $227,000
Q1 2023

May 17, 2023

SELL
$8.36 - $11.37 $18,350 - $24,957
-2,195 Reduced 14.99%
12,448 $110,000
Q4 2022

Feb 10, 2023

SELL
$7.95 - $9.48 $429 - $511
-54 Reduced 0.37%
14,643 $133,000
Q3 2022

Dec 05, 2022

BUY
$6.86 - $11.95 $487 - $848
71 Added 0.49%
14,697 $119,000
Q2 2022

Aug 02, 2022

SELL
$7.38 - $10.4 $2,804 - $3,952
-380 Reduced 2.53%
14,626 $110,000
Q1 2022

May 13, 2022

SELL
$7.33 - $9.39 $14,660 - $18,780
-2,000 Reduced 11.76%
15,006 $141,000
Q4 2021

Feb 01, 2022

BUY
$7.9 - $10.19 $5,530 - $7,133
700 Added 4.29%
17,006 $136,000
Q3 2021

Nov 12, 2021

SELL
$8.38 - $10.18 $4,190 - $5,090
-500 Reduced 2.98%
16,306 $159,000
Q2 2021

Aug 10, 2021

BUY
$9.9 - $11.56 $2,989 - $3,491
302 Added 1.83%
16,806 $166,000
Q1 2021

Apr 30, 2021

BUY
$10.34 - $12.81 $63,229 - $78,333
6,115 Added 58.86%
16,504 $190,000
Q4 2020

Jan 25, 2021

SELL
$8.61 - $11.04 $3,444 - $4,416
-400 Reduced 3.71%
10,389 $100,000
Q2 2020

Aug 13, 2020

SELL
$8.12 - $13.12 $64 - $104
-8 Reduced 0.07%
10,789 $133,000
Q1 2020

Apr 21, 2020

BUY
$6.69 - $13.45 $53 - $107
8 Added 0.07%
10,797 $97,000
Q4 2019

Feb 12, 2020

BUY
$6.53 - $10.72 $70,452 - $115,658
10,789 New
10,789 $106,000
Q3 2018

Nov 05, 2018

SELL
$21.06 - $25.65 $370,066 - $450,721
-17,572 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$16.77 - $24.71 $294,682 - $434,204
17,572 New
17,572 $427,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.